Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-004867
Filing Date
2025-02-20
Accepted
2025-02-20 16:22:32
Documents
1
Period of Report
2025-02-18

Document Format Files

Seq Description Document Type Size
1 form4-02202025_090226.html 4  
1 form4-02202025_090226.xml 4 4111
  Complete submission text file 0001415889-25-004867.txt   5517
Mailing Address C/O BIOAGE LABS, INC. 1445A SOUTH 50TH STREET RICHMOND CA 94804
Business Address
RUBIN PAUL D (Reporting) CIK: 0001210905 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42279 | Film No.: 25645779

Mailing Address 1445A SOUTH 50TH STREET RICHMOND CA 94804
Business Address 1445A SOUTH 50TH STREET RICHMOND CA 94804 510-806-1445
BioAge Labs, Inc. (Issuer) CIK: 0001709941 (see all company filings)

EIN.: 474721157 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)